401 related articles for article (PubMed ID: 26783378)
21. The canine kallikrein-related peptidase 14: structural characterization, alternative splicing and differential expression in mammary cancer.
Angelopoulou K; Prassas I; Yousef GM
Gene; 2009 Oct; 446(2):68-74. PubMed ID: 19619623
[TBL] [Abstract][Full Text] [Related]
22. Mass spectrometry based proteomics analyses in kallikrein-related peptidase research: implications for cancer research and therapy.
Silva LM; Clements JA
Expert Rev Proteomics; 2017 Dec; 14(12):1119-1130. PubMed ID: 29025353
[TBL] [Abstract][Full Text] [Related]
23. New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family.
Emami N; Diamandis EP
Mol Oncol; 2007 Dec; 1(3):269-87. PubMed ID: 19383303
[TBL] [Abstract][Full Text] [Related]
24. Regulation of kallikrein-related peptidases in the skin - from physiology to diseases to therapeutic options.
Fischer J; Meyer-Hoffert U
Thromb Haemost; 2013 Sep; 110(3):442-9. PubMed ID: 23446429
[TBL] [Abstract][Full Text] [Related]
25. Kallikrein-related peptidases (KLKs) in gastrointestinal cancer: mechanistic and clinical aspects.
Kontos CK; Mavridis K; Talieri M; Scorilas A
Thromb Haemost; 2013 Sep; 110(3):450-7. PubMed ID: 23446315
[TBL] [Abstract][Full Text] [Related]
26. Seminal fluid characterization for male fertility and prostate cancer: kallikrein-related serine proteases and whole proteome approaches.
Veveris-Lowe TL; Kruger SJ; Walsh T; Gardiner RA; Clements JA
Semin Thromb Hemost; 2007 Feb; 33(1):87-99. PubMed ID: 17253195
[TBL] [Abstract][Full Text] [Related]
27. Kallikrein-related peptidases: bridges between immune functions and extracellular matrix degradation.
Sotiropoulou G; Pampalakis G
Biol Chem; 2010 Apr; 391(4):321-31. PubMed ID: 20180637
[TBL] [Abstract][Full Text] [Related]
28. Utility of kallikrein-related peptidases (KLKs) as cancer biomarkers.
Emami N; Diamandis EP
Clin Chem; 2008 Oct; 54(10):1600-7. PubMed ID: 18687738
[TBL] [Abstract][Full Text] [Related]
29. Kallikrein-related peptidases in lung diseases.
Lenga Ma Bonda W; Iochmann S; Magnen M; Courty Y; Reverdiau P
Biol Chem; 2018 Sep; 399(9):959-971. PubMed ID: 29604204
[TBL] [Abstract][Full Text] [Related]
30. Human kallikrein-related peptidase 14 (KLK14) is a new activator component of the KLK proteolytic cascade. Possible function in seminal plasma and skin.
Emami N; Diamandis EP
J Biol Chem; 2008 Feb; 283(6):3031-3041. PubMed ID: 18056261
[TBL] [Abstract][Full Text] [Related]
31. The miRNA-kallikrein axis of interaction: a new dimension in the pathogenesis of prostate cancer.
White NM; Youssef YM; Fendler A; Stephan C; Jung K; Yousef GM
Biol Chem; 2012 Apr; 393(5):379-89. PubMed ID: 22505520
[TBL] [Abstract][Full Text] [Related]
32. Kallikreins emerge as new regulators of viral infections.
Pampalakis G; Zingkou E; Panagiotidis C; Sotiropoulou G
Cell Mol Life Sci; 2021 Nov; 78(21-22):6735-6744. PubMed ID: 34459952
[TBL] [Abstract][Full Text] [Related]
33. Activation profiles of human kallikrein-related peptidases by matrix metalloproteinases.
Yoon H; Blaber SI; Li W; Scarisbrick IA; Blaber M
Biol Chem; 2013 Jan; 394(1):137-47. PubMed ID: 23241590
[TBL] [Abstract][Full Text] [Related]
34. Inhibitors of kallikrein-related peptidases: An overview.
Masurier N; Arama DP; El Amri C; Lisowski V
Med Res Rev; 2018 Mar; 38(2):655-683. PubMed ID: 28609548
[TBL] [Abstract][Full Text] [Related]
35. Kallikrein-related peptidases in prostate, breast, and ovarian cancers: from pathobiology to clinical relevance.
Avgeris M; Mavridis K; Scorilas A
Biol Chem; 2012 Apr; 393(5):301-17. PubMed ID: 22505514
[TBL] [Abstract][Full Text] [Related]
36. Kallikrein-related peptidases: proteolysis and signaling in cancer, the new frontier.
Oikonomopoulou K; Diamandis EP; Hollenberg MD
Biol Chem; 2010 Apr; 391(4):299-310. PubMed ID: 20180639
[TBL] [Abstract][Full Text] [Related]
37. Kallikrein-related peptidase (KLK) family mRNA variants and protein isoforms in hormone-related cancers: do they have a function?
Tan OL; Whitbread AK; Clements JA; Dong Y
Biol Chem; 2006 Jun; 387(6):697-705. PubMed ID: 16800730
[TBL] [Abstract][Full Text] [Related]
38. Selective cleavage of human sex hormone-binding globulin by kallikrein-related peptidases and effects on androgen action in LNCaP prostate cancer cells.
Sanchez WY; de Veer SJ; Swedberg JE; Hong EJ; Reid JC; Walsh TP; Hooper JD; Hammond GL; Clements JA; Harris JM
Endocrinology; 2012 Jul; 153(7):3179-89. PubMed ID: 22547569
[TBL] [Abstract][Full Text] [Related]
39. Human kallikrein-related peptidase 12: antibody generation and immunohistochemical localization in prostatic tissues.
Memari N; Diamandis EP; Earle T; Campbell A; Van Dekken H; Van der Kwast TH
Prostate; 2007 Sep; 67(13):1465-74. PubMed ID: 17654496
[TBL] [Abstract][Full Text] [Related]
40. The GNA13-RhoA signaling axis suppresses expression of tumor protective Kallikreins.
Teo CR; Casey PJ; Rasheed SA
Cell Signal; 2016 Oct; 28(10):1479-88. PubMed ID: 27424208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
